Article info
PDFLetter
Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy
- Correspondence to Dr Michael R Ehrenstein, Centre for Rheumatology, Division of Medicine, University College London, London WC1E 6JF, UK; m.ehrenstein{at}ucl.ac.uk
Citation
Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy
Publication history
- Received April 23, 2021
- Accepted June 14, 2021
- First published June 23, 2021.
Online issue publication
February 28, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.